1,150
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: EPIDEMIOLOGY

Comorbidity and early death in Danish stage I lung cancer patients – an individualised approach

, , , &
Pages 994-1001 | Received 29 Nov 2019, Accepted 28 Apr 2020, Published online: 28 May 2020

References

  • Wong MCS, Lao XQ, Ho K-F, et al. Incidence and mortality of lung cancer: global trends and association with socioeconomic status. Sci Rep. 2017;7(1):14300.
  • Ceniceros L, Aristu J, Castañón E, et al. Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients. Clin Transl Oncol. 2016;18(3):259–268.
  • Bi N, Shedden K, Zheng X, et al. Comparison of the effectiveness of radiofrequency ablation with stereotactic body radiation therapy in inoperable stage I non-small cell lung cancer: a systemic review and pooled analysis. Int J Radiat Oncol. 2016;95(5):1378–1390.
  • Ezer N, Veluswamy RR, Mhango G, et al. Outcomes after stereotactic body radiotherapy versus limited resection in older patients with early-stage lung cancer. J Thorac Oncol. 2015;10(8):1201–1206.
  • U.S. Department of Health and Human Services. The health consequences of smoking: a report of the surgeon general. Atlanta (GA): Centers for Disease Control and Prevention; 2004.
  • Peto R, Darby S, Deo H, et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 2000;321(7257):323–329.
  • Taghizadeh N, Vonk JM, Boezen HM. Lifetime smoking history and cause-specific mortality in a cohort study with 43 years of Follow-up. PLoS One. 2016;11(4):e0153310–18.
  • Simonsen DF, Søgaard M, Bozi I, et al. Risk factors for postoperative pneumonia after lung cancer surgery and impact of pneumonia on survival. Respir Med. 2015;109(10):1340–1346.
  • Islam KMM, Jiang X, Anggondowati T, et al. Comorbidity and survival in lung cancer patients. Cancer Epidemiol Biomarkers Prev. 2015;24(7):1079–1085.
  • Rios J, Gosain R, Goulart BHL, et al. Treatment and outcomes of non-small-cell lung cancer patients with high comorbidity. CMAR. 2018;10:167–175.
  • Janssen-Heijnen ML, Schipper RM, Razenberg PP, et al. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer. 1998;21(2):105–113.
  • Ganti AK, Siedlik E, Marr AS, et al. Predictive ability of Charlson Comorbidity Index on outcomes from lung cancer. Am J Clin Oncol. 2011;34(6):593–596.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
  • Thygesen SK, Christiansen CF, Lash TL, et al. Predictive value of coding of diagnoses in the charlson comorbidity index in the Danish national registry of patients. Pharmacoepidemiol Drug Saf. 2009;18(S1):S189.
  • Lüchtenborg M, Morris EJA, Tataru D, et al. Investigation of the international comparability of population-based routine hospital data set derived comorbidity scores for patients with lung cancer. Thorax. 2018;73(4):339–349.
  • Parés-Badell O, Banqué M, Macià F, et al. Impact of comorbidity on survival by tumour location: Breast, colorectal and lung cancer (2000-2014). ).Cancer Epidemiol. 2017;49:66–74.
  • Suppli NP, Johansen C, Kessing LV, et al. Survival after early-stage breast cancer of women previously treated for depression: a nationwide Danish cohort study. J Clin Oncol. 2017;35(3):334–342.
  • Jakobsen E, Green A, Oesterlind K, et al. Nationwide quality improvement in lung cancer care: the role of the Danish Lung Cancer Group and Registry. J Thorac Oncol. 2013;8(10):1238–1247.
  • Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39(7 Suppl):42–45.
  • Danish Health Authority. [cited 2020 May 14]. Available form: https://www.sst.dk/en/health-and-lifestyle/alcohol.
  • Christensen N, Kejs AM, Jakobsen E, et al. Early death in Danish stage I lung cancer patients. A population-based case study. Acta Oncol (Madr). 2018;57(11):1561–1566.
  • Christensen NL, Dalton S, Ravn J, et al. Treatment, no treatment and early death in Danish stage I lung cancer patients. Lung Cancer. 2019;131:1–5.
  • Onaitis M, D'Amico T, Zhao Y, et al. Risk factors for atrial fibrillation after lung cancer surgery: Analysis of the society of thoracic surgeons general thoracic surgery database. Ann Thorac Surg. 2010;90(2):368–374.
  • Imperatori A, Mariscalco G, Riganti G, et al. Atrial fibrillation after pulmonary lobectomy for lung cancer affects long-term survival in a prospective single-center study. J Cardiothorac Surg. 2012;7(1):1–8.
  • Sekine Y, Kesler KA, Behnia M, et al. COPD may increase the incidence of refractory supraventricular arrhythmias following pulmonary resection for non-small cell lung cancer. Chest. 2001;120(6):1783–1790.
  • Christensen NL, Løkke A, Dalton SO, et al. Smoking, alcohol, and nutritional status in relation to one-year mortality in Danish stage I lung cancer patients. Lung Cancer. 2018;124:40–44.
  • De Goede B, Klitsie PJ, Lange JF, et al. Morbidity and mortality related to non-hepatic surgery in patients with liver cirrhosis: a systematic review. Best Pract Res Clin Gastroenterol. 2012;26(1):47–59.
  • Walters S, ICBP Module 1 Working Group, Maringe C, Coleman MP, et al. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007. Thorax. 2013;68(6):551–564.
  • Nilsson J, Berglund A, Bergström S, et al. The role of comorbidity in the management and prognosis in nonsmall cell lung cancer: a population-based study. Acta Oncol. 2017;56(7):949–956.
  • Vodermaier A, Lucas S, Linden W, et al. Anxiety after diagnosis predicts lung cancer-specific and overall survival in patients with stage III non-small cell lung cancer: a population-based cohort study . J Pain Symptom Manage. 2017;53(6):1057–1065.
  • Cooley ME, Wang Q, Johnson BE, et al. Factors associated with smoking abstinence among smokers and recent-quitters with lung and head and neck cancer. Lung Cancer. 2012;76(2):144–149.
  • Vogt A, Schmid S, Heinimann K, et al. Multiple primary tumours : challenges and approaches, a review. 2017;2:e000172.
  • Schildt E, Eriksson M, Hardell L, et al. Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case-control study. Int J Cancer. 1998;77(3):341–346.
  • Tammemagi CM, Neslund-Dudas C, Simoff M, et al. In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival. J Clin Epidemiol. 2004;57(6):597–609.
  • Iachina M, Green A, Jakobsen E. The direct and indirect impact of comorbidity on the survival of patients with non-small cell lung cancer: a combination of survival, staging and resection models with missing measurements in covariates. BMJ Open. 2014;4(2):e003846.
  • Mokhles S, Nuyttens JJ, Maat A, et al. Survival and treatment of non-small cell lung cancer stage I – II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis. Ann Surg Oncol. 2015;22(1):316–323.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.